Signs of clinical inflammation and principles of monitoring disease activity in inflammatory rheumatic diseases

Clinical signs

Clinical signs of inflammation (the classical rubor, calor, tumor, dolor, functio laesa) apply to joint assessment as much as any other tissue, and systematic joint examination combined with disease activity scoring underpins objective monitoring of inflammatory rheumatic disease
Applied routinely at every clinical review of a patient with known or suspected inflammatory arthritis, complementing patient-reported symptoms and laboratory markers

Active synovitis produces warmth (calor, from increased local blood flow), swelling (tumor, from synovial proliferation and effusion), tenderness (dolor), and reduced range of motion (functio laesa) - the same underlying pannus/cytokine-driven process described in the joint inflammation pathophysiology note, manifesting as directly examinable clinical signs

Tender and swollen joint counts are the core clinical components of validated composite disease activity scores (e.g. DAS28 in RA, combining joint counts, ESR/CRP, and patient global assessment) - used to objectively track disease activity over time and guide treat-to-target treatment escalation decisions
Distinguishing active synovitis (warm, swollen, tender, boggy) from secondary/mechanical joint changes (bony swelling without warmth, e.g. established osteoarthritis) is an essential clinical skill, since the two require entirely different management approaches

Composite disease activity scores (DAS28 and equivalents for other conditions) directly guide treat-to-target management - escalating therapy when the score indicates inadequate disease control (not in remission/low disease activity), rather than relying on subjective impression alone
Regular, structured reassessment (not just symptom-triggered review) is central to modern inflammatory arthritis management, given how much better long-term outcomes are with tight, objectively-monitored disease control

DAS28 and other composite disease activity indices, treat-to-target strategy in rheumatoid arthritis, distinguishing inflammatory from mechanical joint pain

The shift from subjective, symptom-triggered management toward objective, composite-score-driven "treat to target" management has been one of the most significant advances in modern rheumatology practice, demonstrably improving long-term structural and functional outcomes compared with less systematic monitoring approaches

5 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.